Meyka Pro banner
Solventum Corporation

Solventum Corporation Fundamental Analysis (NYSE: SOLV)

SOLV●NYSE
HealthcareMedical - Instruments & Supplies
$88.81
$0.19(0.21%)
U.S. Market opens in 15h 28m

Solventum Corporation Fundamental Analysis (NYSE: SOLV)

Solventum Corporation (NYSE: SOLV) shows weak financial fundamentals with a PE ratio of 99.79, profit margin of 1.91%, and ROE of 3.18%. The company generates $8.1B in annual revenue with weak year-over-year growth of 0.86%.

Key Strengths

Operating Margin24.60%
PEG Ratio-1.11

Areas of Concern

ROE3.18%
Cash Position2.97%
We analyze SOLV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 19.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
19.7/100

We analyze SOLV's fundamental strength across five key dimensions:

Efficiency Score

Weak

SOLV struggles to generate sufficient returns from assets.

ROA > 10%
1.10%

Valuation Score

Moderate

SOLV shows balanced valuation metrics.

PE < 25
99.79
PEG Ratio < 2
-1.11

Growth Score

Weak

SOLV faces weak or negative growth trends.

Revenue Growth > 5%
0.86%
EPS Growth > 10%
2.23%

Financial Health Score

Moderate

SOLV shows balanced financial health with some risks.

Debt/Equity < 1
1.10
Current Ratio > 1
1.03

Profitability Score

Weak

SOLV struggles to sustain strong margins.

ROE > 15%
3.18%
Net Margin ≥ 15%
1.91%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is SOLV Expensive or Cheap?

P/E Ratio

SOLV trades at 99.79 times earnings. This suggests a premium valuation.

99.79

PEG Ratio

When adjusting for growth, SOLV's PEG of -1.11 indicates potential undervaluation.

-1.11

Price to Book

The market values Solventum Corporation at 3.16 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.16

EV/EBITDA

Enterprise value stands at 12.82 times EBITDA. This signals the market has high growth expectations.

12.82

How Well Does SOLV Make Money?

Net Profit Margin

For every $100 in sales, Solventum Corporation keeps $1.91 as profit after all expenses.

1.91%

Operating Margin

Core operations generate 24.60 in profit for every $100 in revenue, before interest and taxes.

24.60%

ROE

Management delivers $3.18 in profit for every $100 of shareholder equity.

3.18%

ROA

Solventum Corporation generates $1.10 in profit for every $100 in assets, demonstrating efficient asset deployment.

1.10%

Following the Money - Real Cash Generation

Operating Cash Flow

Solventum Corporation generates limited operating cash flow of $310.46M, signaling weaker underlying cash strength.

$310.46M

Free Cash Flow

Solventum Corporation generates weak or negative free cash flow of $1.99M, restricting financial flexibility.

$1.99M

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

SOLV converts 0.01% of its market value into free cash.

0.01%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

99.79

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.85

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.10

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.01

vs 25 benchmark

ROCE

Return on capital employed

0.19

vs 25 benchmark

How SOLV Stacks Against Its Sector Peers

MetricSOLV ValueSector AveragePerformance
P/E Ratio99.7931.30 Worse (Expensive)
ROE3.18%487.00% Weak
Net Margin1.91%-1832.00% (disorted) Weak
Debt/Equity1.100.10 Weak (High Leverage)
Current Ratio1.035.74 Neutral
ROA1.10%-165.00% (disorted) Weak

SOLV outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Solventum Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

13.27%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

35.45%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-81.96%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ